QA: Y mAbs Therapeutics Inc in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001722964_2019_Y_mAbs_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001722964, Y mAbs Therapeutics Inc

  xvar xval
0 AssetsCurrent 151,532,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 205,000
3 remainder_Assets 187,000
4 LiabilitiesCurrent 9,123,000
5 LiabilitiesNoncurrent 224,000
6 remainder_Liabilities 2,050,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 8,961,000
9 ResearchAndDevelopmentExpense 34,269,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -44,000
13 remainder_ComprehensiveNetIncome 175,000
  yvar yval
0 Assets 151,924,000
1 Liabilities 11,397,000
2 Expenses 43,230,000
3 Revenues 0
4 StockholdersEquity 140,527,000
5 NetIncome -43,274,000
6 ComprehensiveNetIncome -43,186,500
7 BaseVar 103,385,000
8 EconomicCapitalRatiobeforeLimitedLiability 3.22
9 EconomicCapitalRatio 3.84

Edgar->Model Mapping

Feature Distribution